A52 PRECLINICAL TRIALS IN PULMONARY HYPERTENSION MODELS: NOVEL TARGETS AND DELIVERY: The Single Isomer Beraprost-314d Has Disproportionate And Superior Prostacyclin (ip) Receptor And Antiproliferative Activity Compared With Beraprost

A52 PRECLINICAL TRIALS IN PULMONARY HYPERTENSION MODELS: NOVEL TARGETS AND DELIVERY: The Single Isomer Beraprost-314d Has Disproportionate And Superior Prostacyclin (ip) Receptor And Antiproliferative Activity Compared With Beraprost

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine Vol. 191; p. 1
Main Authors: Clapp, L H, Shen, L, Patel, J, Von Kessler, K R B, Laing, P, Sista, P
Format: Journal Article
Language:English
Published: New York American Thoracic Society 01-01-2015
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1073-449X
1535-4970